CompletedPhase 2NCT04027036

Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto Nacional de Saúde, Mozambique
Principal Investigator
Edna Viegas, MD,PhD
INS-CISPOC
Intervention
Inactivated poliovirus vaccine in reduced doses(biological)
Enrollment
382 target
Eligibility
All sexes
Timeline
2020 – 2022

Study locations (2)

Collaborators

World Health Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04027036 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials